Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ardelyx
Biotech
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Cox named new CEO of Dyne. Ex-Madrigal US sales chief named CCO of Nuvation. Longtime NIAID leader leaves for CSO gig at Alphabet's Calico.
Max Bayer
,
Gabrielle Masson
Mar 29, 2024 9:30am
FDA denies Ardelyx's appeal against kidney drug rejection
Feb 10, 2022 9:36am
Goldfinch nabs 13-year Ardelyx vet as CSO to advance kidney drug
Dec 6, 2021 10:30am
Ardelyx's FDA rejection points to long path back for CKD drug
Jul 30, 2021 8:05am
Ardelyx stock craters as it's hit with FDA 'deficiencies' tag
Jul 20, 2021 6:45am
Ardelyx's kidney disease drug hits goal in phase 3
Dec 3, 2019 8:39am
